Status:

RECRUITING

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

Lead Sponsor:

Radboud University Medical Center

Collaborating Sponsors:

PENTA Foundation

Merck Sharp & Dohme LLC

Conditions:

HIV Infections

Eligibility:

FEMALE

18+ years

Brief Summary

Due to the potential for pregnancy-induced changes in the pharmacokinetics of medication, one cannot assume that the currently licensed doses of the medication to be tested under this protocol lead to...

Detailed Description

The following agents will be studied: Etravirine, Intelence, TMC125; Emtricitabine, Emtriva or FTC; Tenofovir, Viread, TDF; Atazanavir, Reyataz; Fosamprenavir, Telzir, FPV; Darunavir, Prezista, TMC11...

Eligibility Criteria

Inclusion

  • HIV-infected as documented by positive HIV antibody test and confirmed by an antigen test.
  • Subject is at least 18 years of age at screening.
  • Subject is able and willing to sign the Informed Consent Form prior to screening evaluations.
  • Treated with a cART regimen containing at least one agent which is mentioned in Appendix 1; this agent has been taken for at least 2 weeks before the day of first PK curve evaluation.
  • Subject is pregnant
  • Subject is able to adhere to food intake recommendations, if applicable.

Exclusion

  • Relevant history or current condition that might interfere with drug absorption, distribution, metabolism or excretion.
  • Inability to understand the nature and extent of the study and the procedures required.
  • Presence of grade III/IV anemia (i.e. Hb \<4.6 mmol/L or \<7.4 g/dL).
  • Using oral cabotegravir/rilpivirine.

Key Trial Info

Start Date :

February 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

176 Patients enrolled

Trial Details

Trial ID

NCT00825929

Start Date

February 1 2009

End Date

December 1 2026

Last Update

January 13 2025

Active Locations (21)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (21 locations)

1

Saint-Pierre University Hospital; Department of Infectious Diseases

Brussels, Belgium

2

CHARITÉ Berlin

Berlin, Germany

3

University of Bonn

Bonn, Germany

4

University of Cologne

Cologne, Germany